loader

bluebird bio

LATEST ARTICLES
Investing in Stem Cell Treatments

Investing in Stem Cell Treatments

NASDAQ:BLUE

bluebird bio and Gritstone Oncology to Collaborate

bluebird bio and Gritstone Oncology Announce Strategic Collaboration to Develop Novel Cancer Cell Therapies

Biotech Investing

Biotech Outlook 2018: New Partnerships Seeking Consolidation in an Expansive Market

Genetics Investing

4 Gene Therapy Stocks to Watch in 2017

Biotech Investing

Investing in Immuno-Oncology: A Q&A with TapImmune's John Bonfiglio

Biotech Investing

Bluebird Bio Scores Win for Immunotherapy Market

bluebird bio and Medigene Establish Strategic T Cell Receptor Alliance in Cancer Immunotherapy

Genetics Investing

Bluebird bio's LentiGlobin Accepted to PRIME Program

Why Is Biotech Down and Will It Stay That Way?

Why Is Biotech Down and Will It Stay That Way?

bluebird bio Reports First Quarter 2016 Financial Results and Recent Operational Progress

Biotech Investing

Global Blood Therapeutics Debuts with Successful $120-million IPO

Latest News

More News